Evidence map›Paper›PMID 24370461›Full record

ReviewBrain, behavior, and immunity2014

The role of microbiome in central nervous system disorders.

Yan Wang, Lloyd H Kasper

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Brain, behavior, and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 359 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
359citing papers in PubMed, 7 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02477904 nacompletednot on this mapstarted 2015, after this paper: background citation

Ketogenic Diet Therapy for Autism Spectrum Disorder

TypeinterventionalSponsorShriners Hospitals for ChildrenRan2015 to 2017Enrolled119ConditionsAutism Spectrum DisorderArmsKetogenic Diet
NCT03279224 phase2 / phase3unknown statusnot on this mapstarted 2018, after this paper: background citation

A Randomized Controlled Trial of the Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder

TypeinterventionalSponsorValerie TaylorRan2018 to 2022Enrolled35ConditionsBipolar DepressionArmsAllogenic FMT, Autologous FMT
NCT06279858 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Probiotic Intervention for Microbiome Modifications and Consequential Clinical Improvements in Children With Fragile X Syndrome: Pilot Study

TypeinterventionalSponsorSpecila hospital for cerebral palsy and developmental neurologyRan2024 to 2024Enrolled15ConditionsFragile X SyndromeArmsProbiotics
3 · Its place in the literature

Who cites it

359 citing papers in PubMed, 7 syntheses or guidelines pooled it, 788 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Review
  13. Gut-Brain Signaling in Parkinson's Disease: A Narrative Review.International journal of molecular sciences · 2026
    Review
  14. Review
  15. Intermittent Fasting andNutrients · 2026
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

299 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yan WangDepartment of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA; Department of Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA.
Lloyd H KasperDepartment of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA; Department of Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA. Electronic address: Lloyd.H.Kasper@dartmouth.edu.
Dartmouth College · US

Funding

GALT mediated protection against CNS demyelination: Role of commensal bacteriaR56AI098282 · NIAID · DARTMOUTH COLLEGE · PI KASPER, LLOYD H · 2012 to 2012
$277k
NIAID NIH HHS R56 AI098282
6 · The paper itself

Abstract

Mammals live in a co-evolutionary association with the plethora of microorganisms that reside at a variety of tissue microenvironments. The microbiome represents the collective genomes of these co-existing microorganisms, which is shaped by host factors such as genetics and nutrients but in turn is able to influence host biology in health and disease. Niche-specific microbiome, prominently the gut microbiome, has the capacity to effect both local and distal sites within the host. The gut microbiome has played a crucial role in the bidirectional gut-brain axis that integrates the gut and central nervous system (CNS) activities, and thus the concept of microbiome-gut-brain axis is emerging. Studies are revealing how diverse forms of neuro-immune and neuro-psychiatric disorders are correlated with or modulated by variations of microbiome, microbiota-derived products and exogenous antibiotics and probiotics. The microbiome poises the peripheral immune homeostasis and predisposes host susceptibility to CNS autoimmune diseases such as multiple sclerosis. Neural, endocrine and metabolic mechanisms are also critical mediators of the microbiome-CNS signaling, which are more involved in neuro-psychiatric disorders such as autism, depression, anxiety, stress. Research on the role of microbiome in CNS disorders deepens our academic knowledge about host-microbiome commensalism in central regulation and in practicality, holds conceivable promise for developing novel prognostic and therapeutic avenues for CNS disorders.

Indexed as

MicrobiotaAnimalsBrainCentral Nervous System DiseasesGastrointestinal TractHumansCentral nervous systemGut–brain axisMicrobiomeNeuro-immune disordersNeuro-psychiatric disorders

Identifiers

PMID24370461
PMCPMC4062078
OpenAlexW1991521547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.